Evidence map›Paper›PMID 19107146›Full record

ArticleEuropean journal of human genetics : EJHG2009

A targeted population carrier screening program for severe and frequent genetic diseases in Israel.

Joël Zlotogora, Rivka Carmi, Boaz Lev, Stavit A Shalev

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. RareBrain communications · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Novel therapeutic approaches for the primary hyperoxalurias.Pediatric nephrology (Berlin, Germany) · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Responsible implementation of expanded carrier screening.European journal of human genetics : EJHG · 2016
    Article
  14. The Israeli national population program of genetic carrier screening for reproductive purposes.Genetics in medicine : official journal of the American College of Medical Genetics · 2016
    Article
  15. Genetics and genomic medicine in Israel.Molecular genetics & genomic medicine · 2014
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Joël ZlotogoraDepartment of Community Genetics, Public Health Services, Ministry of Health and the Hebrew University Jerusalem, Tel Hashomer, Ramat Gan, Israel. joelz@cc.huji.ac.il
Rivka Carmi
Boaz Lev
Stavit A Shalev

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A national carrier screening program targeted at communities in which severe genetic diseases are present with a frequency higher than 1/1000 live births, has been in existence in Israel since 2002. Within the communities at risk, carrier screening is voluntary whereas genetic counseling and testing is provided free of charge. During the first 5 years of the program more than 13 000 tests were performed, and at the end of 2007 it was offered in 35 different localities/communities for a total of 36 diseases. Many of the couples identified to be at risk opted for prenatal diagnosis and in two cases an affected pregnancy was terminated. In some cases the couples declined prenatal diagnosis and two of those families gave birth to an affected child. Based on the experience learnt from this targeted screening program it appears that a knowledge-based, voluntary screening program operated within the community is an effective way to provide genetic services and test referrals. The community program directed toward couples in their reproductive period does not seem to have led to stigmatization at either the individual or the community level.

Indexed as

ChildFemaleGenetic Carrier ScreeningGenetic Diseases, InbornGenetic TestingHumansInfant, NewbornIsraelNeonatal ScreeningPregnancyPrenatal DiagnosisProgram Evaluation

Identifiers

PMID19107146
PMCPMC2986253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.